Liver samples were obtained from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study [21] . PDAY was an autopsy study designed to examine the pathogenesis of atherosclerosis in young people. A subset of the total population, selected for a separate study, consisted of subjects with the lowest 25
th (controls) and highest 10
th (cases) percentile of non-HDL cholesterol. Samples were from 72 European American and 72 African-American males, 15 to 34 years of age, who died of violent causes within 72 hours after injury and underwent autopsy in one of the cooperating medical examiners’ laboratories. DNA was isolated from liver samples that had been stored at −80C. Five hundred to 700 mg of thawed liver tissues were homogenized with a Dispomix Drive (Medic Tools AG, Switzerland) and genomic DNA extracted with a MagneSil Genomic, Large Volume system (Promega, USA) process that had been automated on a
Freedom EVO liquid handler (Tecan, Switzerland). Extracted DNA was quantitated with
PicoGreen reagent (Molecular Probes, USA) and verified as high molecular weight (>50 Kb) by agarose gel electrophoresis. This study used DNA obtained from liver samples acquired at autopsy. Since all study subjects were deceased at the time of study, use of these specimens is not considered Human Subjects research.
Howard T.D., Mathias R.A., Seeds M.C., Herrington D.M., Hixson J.E., Shimmin L.C., Hawkins G.A., Sellers M., Ainsworth H.C., Sergeant S., Miller L.R, & Chilton F.H. (2014). DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver. PLoS ONE, 9(5), e97510.